Home ••• Newswires by Industry • Countries • U.S. States • World Media Directory

Lung Cancer News ••• Topics • Countries • U.S. States

Non-Small Cell Lung Cancer (NSCLC) News Monitoring

Get by Email • RSS

Published on Dec 10, 2025

IBTROZI for the Treatment of Non-small Cell Lung Cancer, US

IBTROZI™ (taletrectinib) is a tyrosine kinase inhibitor indicated for the treatment of adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) associated with an abnormal ROS1 gene. Developed by Nuvation Bio, the targeted oral therapy …

Source: Clinical Trials Arena - Pending
Published on Dec 10, 2025

<![CDATA[How Do Experts Think Dato-DXd Should Be Used in NSCLC?]]>

Datopotamab deruxtecan-dlnk (Dato-DXd; Datroway) was recently approved as a treatment for patients with EGFR-mutated non–small cell lung cancer (NSCLC) who received prior EGFR-directed therapy and platinum-based chemotherapy.1 In the wake of this approval, …

Source: Cancer Network - New Jersey - Pending
Published on Dec 10, 2025

<![CDATA[Emerging Therapies and Future Outlook for Patients with EGFR-Mutant NSCLC]]>

Panelists discuss how the next generation of targeted agents, including sunvozertinib, BLU-945, and antibody-drug conjugates, promises to further refine the treatment paradigm. These emerging therapies aim to address resistance mutations and improve …

Source: Targeted Oncology - Pending
Published on Dec 10, 2025

<![CDATA[Treatment Sequencing in EGFR-Mutant NSCLC]]>

Panelists discuss how anticipating resistance mechanisms such as C797S mutation or MET amplification is essential when designing first-line strategies. Selecting agents with favorable resistance profiles can prolong disease control and preserve future …

Source: Targeted Oncology - Pending
Published on Dec 10, 2025

<![CDATA[Counseling Patients with EGFR-Mutant NSCLC and Shared Decision-Making]]>

Panelists discuss how transparent communication about central nervous system response expectations and overall treatment goals builds patient trust and engagement. When counseling individuals with brain metastases, physicians must balance optimism about …

Source: Targeted Oncology - Pending
Published on Dec 10, 2025

<![CDATA[Guideline Recommendations vs Real-World Experience in Treating Patients With EGFR-Mutant NSCLC]]>

Panelists discuss how real-world practice often diverges from guideline recommendations due to access barriers, toxicity management, and individual patient complexities. Although evidence-based protocols provide structure, clinicians frequently adapt …

Source: Targeted Oncology - Pending
Published on Dec 10, 2025

Durable Tumor Control with Multi-Organ Immune-Related Adverse Events Following Immune Checkpoint Inhibitor and ...

Menglan Zhai,1,&ast; Xianwen Liu,2,&ast; Ying Li,1 Guoliang Pi,1 Jianping Bi,1 Guang Han1 1Department of Radiation Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of …

Source: Dove Medical Press - Neutral
Published on 08:45 GMT

Evodiamine Targets Genes in Cisplatin-Resistant Lung Cancer

In a groundbreaking study that delves into the molecular mechanisms of chemotherapy resistance, researchers have unveiled promising insights into the use of Evodiamine as a potential therapeutic agent against cisplatin-resistant non-small cell lung cancer …

Source: Bioengineer.org - Indeterminate
Published on 10:30 GMT

Bevacizumab Biosimilars Market Drivers 2025-2029: Regional Outlook and Sizing Analysis

The Business Research Company's Bevacizumab Biosimilars Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, December 11, 2025 /⁨EINPresswire.com⁩/ -- "Bevacizumab …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on Dec 9, 2025

<![CDATA[Ivonescimab/Chemo Improves Quality of Life in Frontline Squamous NSCLC]]>

Updated results from the phase 3 HARMONi-6 trial (NCT05840016) demonstrated that patient-reported quality of life outcomes were improved with ivonescimab plus chemotherapy compared with tislelizumab-jsgr (Tevimbra) plus chemotherapy in the treatment of …

Source: Cancer Network - New Jersey - Pending
Published on Dec 10, 2025

BioNTech and BMS’ bispecific touts 59.3% nine-month PFS in TNBC

Bristol Myers Squibb (BMS) and BioNTech’s pumitamig has displayed promising efficacy and safety during a mid-stage trial in front and second-line triple-negative breast cancer (TNBC). During the ongoing Phase II study (NCT06449222), the bispecific …

Source: Clinical Trials Arena - Pending
Published on Dec 9, 2025

<![CDATA[3 Things You Should Know About Future Directions for BsAbs and ADCs in NSCLC]]>

LEARNING OBJECTIVES Upon successful completion of this activity, you should be better prepared to: • Integrate the latest evidence and disease- and patient-specific characteristics into personalized treatment plans for advanced NSCLC • Describe the unique …

Source: Cancer Network - New Jersey - Pending
Published on Dec 10, 2025

Nine small health issues that could be an early sign of lung cancer

Your support helps us to tell the story From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our …

Source: The Independent - Center-left
Published on Dec 10, 2025

Privacy-Preserving Linkage of Cancer and Claims Data

In a groundbreaking study, researchers from Germany have unveiled a new methodology for privacy-preserving record linkage, focusing on the intersection of cancer registry data and claims data related to stage IV non-small cell lung cancer (NSCLC). The …

Source: Bioengineer.org - Indeterminate
Published on Dec 10, 2025

Russia registers innovative drug for lung cancer

The Russian Ministry of Health has approved a new immunotherapy drug for the treatment of non-small cell lung cancer. The treatment will be manufactured in Russia through a full production cycle, which could reduce treatment costs by several billion …

Source: Tunisie Numerique - Neutral
Published on Dec 8, 2025

<![CDATA[MARIPOSA Final OS Results in Asia Population Yield Meaningful Improvement in EGFR NSCLC]]>

A clinically meaningful improvement in overall survival (OS) with amivantamab-vmjw (Rybrevant) plus lazertinib (Lazcluze) was highlighted in the Asian population of the phase 3 MARIPOSA trial (NCT04487080) for patients with locally advanced or metastatic …

Source: Cancer Network - New Jersey - Pending
Published on Dec 8, 2025

<![CDATA[Zenocutuzumab Yields Durable Responses in Treatment-Naïve NRG1+ NSCLC]]>

Zenocutuzumab-zbco (Bizengri) showed potential in patients with treatment-naïve non–small cell lung cancer (NSCLC) harboring an NRG1 gene fusion in results from a post hoc analysis of the phase 2 eNRGy trial (NCT02912949). These results were shared at the …

Source: Cancer Network - New Jersey - Pending
Published on Dec 10, 2025

Development of a Novel Anti-Siglec-15 Antibody for Tumor Immunotherapy

Introduction In the past decade, through clinical research and observation, researchers have identified an important phenomenon - systemic immune activation does not necessarily lead to cancer regression, especially in the treatment of patients with solid …

Source: Dove Medical Press - Neutral
Published on Dec 10, 2025

The Modified Shuyu Pill Inhibits the Formation of Pre-Metastatic Niches in Triple-Negative Breast Cancer by Reducing the ...

Introduction Triple-negative breast cancer (TNBC) is a subtype of breast cancer for approximately 15%-20% of all breast cancer cases with highly malignant, difficult to treat, and prone to metastasis.1,2 The treatment of TNBC depends on the subtype and …

Source: Dove Medical Press - Neutral

21 days 22:49:22

Featured Releases

Got News to Share? · Submit · See All

Published on December 11, 2025 - 09:12 GMT

Senate Resolution 203 Printer's Number 1355

PENNSYLVANIA, December 10 - PRINTER'S NO. 1355 THE GENERAL ASSEMBLY OF PENNSYLVANIA SENATE RESOLUTION No. 203 Session of 2025 INTRODUCED BY CULVER, PICOZZI, BROOKS, HUGHES, BARTOLOTTA, TARTAGLIONE, FONTANA, MARTIN, BROWN, HAYWOOD, VOGEL, STREET, J. …

Distribution channels:
Published on December 11, 2025 - 10:30 GMT

Bevacizumab Biosimilars Market Drivers 2025-2029: Regional Outlook and Sizing Analysis

The Business Research Company's Bevacizumab Biosimilars Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, December 11, 2025 /⁨EINPresswire.com⁩/ -- "Bevacizumab …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on December 9, 2025 - 10:45 GMT

US Navy Veterans Mesothelioma and Lung Cancer Advocates Offer an Honest Service Nationwide to Ensure a Navy Submarine ...

WASHINGTON, DC, UNITED STATES, December 9, 2025 /⁨EINPresswire.com⁩/ -- According to the US Navy Veterans Mesothelioma Advocate and the US Navy Veterans Lung Cancer Advocate, "If your husband or dad is a US Navy Submarine Veteran and he has …

Distribution channels: Automotive Industry, Building & Construction Industry ...
Published on December 10, 2025 - 12:33 GMT

Respiration Sensor Market Size Estimated To Reach $477.0 Million By 2033

The respiration sensor market was valued at $250.8 million in 2023 and is estimated to reach $477.0 million by 2033, growing at a CAGR of 6.7% WILMINGTON, DE, UNITED STATES, December 10, 2025 /⁨EINPresswire.com⁩/ -- The demand for respiration …

Distribution channels: Business & Economy, Electronics Industry ...

Published on December 6, 2025 - 20:30 GMT

BioNTech and OncoC4 Announce Clinically Meaningful Overall Survival Benefit for Selective Treg Modulator Gotistobart in ...

Selective Treg modulator gotistobart (BNT316/ONC-392) showed a reduction in the risk of death by more than half compared to standard of care chemotherapy and a manageable safety profile in the first of two stages of the global Phase 3 trial PRESERVE- …

Distribution channels: Media, Advertising & PR, Technology ...
Published on December 10, 2025 - 21:05 GMT

BBOT Announces Late-Breaking Preclinical Data on BBO-10203, a First-in-Class RAS:PI3Kα Breaker, at the San Antonio ...

Preclinical data demonstrate BBO-10203 blocks RAS-mediated activation of PI3Kα, strongly inhibits pAKT signaling in tumor cells without inducing hyperglycemia, and shows robust anti-tumor activity both as monotherapy and in combination with standard of …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...
Published on December 10, 2025 - 19:00 GMT

MAIA Takes Aim at a $50B Immunotherapy Market with Breakthrough Telomere-Targeting Approach

CHICAGO, Dec. 10, 2025 (GLOBE NEWSWIRE) -- MAIA Biotechnology (NYSE American: MAIA) – The treatment paradigm for advanced non-small cell lung cancer (NSCLC) is undergoing another shift. After a decade of targeted therapies and checkpoint inhibitors (CPIs) …

Distribution channels: Technology ...
Published on December 10, 2025 - 18:30 GMT

Carrick Therapeutics Announces Positive Results from Phase 2 Randomized Trial of Samuraciclib in Combination with ...

Overall response rate (ORR) of 55% and median progression-free survival of 14.5 months in patients without TP53 gene mutation Phase 2 results presented at 2025 San Antonio Breast Cancer Symposium BOSTON, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Carrick …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Got news to share? Submit it now.

Load more lung cancer news or search news using your own keywords. There are 874,501,438 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Lung Cancer News by Country

Lung Cancer News by U.S. State

Lung Cancer News Topics

Online News Publications

World News Report

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter

Create RSS Feed

NewsPlugin for WordPress

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire

Events

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 11/14/2025

World Media Directory

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Published on December 11, 2025 - 10:56 GMT

Cybersecurity Leadership Book helps Leaders with Ancient Vedic and Western Wisdom

Strategic GRC Based on Real World Case Studies DENVER, CO, UNITED STATES, December 11, 2025 /⁨EINPresswire.com⁩/ -- As cyber incidents escalate and global regulatory pressure rises, organisations are struggling not just with technology gaps but with …

Distribution channels: Consumer Goods, Healthcare & Pharmaceuticals Industry ...
Published on December 11, 2025 - 10:53 GMT

Chinese Neurosurgical Journal Study Reveals High Paralysis Risk in corticospinal tract-Infiltrating Gliomas

Gliomas invading the brain’s motor pathway significantly increase long-term paralysis risk, highlighting urgent need for cautious surgical strategies BEIJING, BEIJING, CHINA, December 11, 2025 /⁨EINPresswire.com⁩/ -- Researchers at Beijing Tiantan …

Distribution channels: Culture, Society & Lifestyle, Education ...
Published on December 11, 2025 - 10:30 GMT

Antibody Production Market: Analysis of Future Demand and Leading Key Players Through 2029

The Business Research Company’s Antibody Production Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, December 11, 2025 /⁨EINPresswire.com⁩/ -- The antibody production market has become …

Distribution channels: Business & Economy, Chemical Industry ...
Published on December 11, 2025 - 10:30 GMT

Market Size, Share, Competitive Landscape, and Trend Analysis Report for Antibody Production Services

The Business Research Company’s Antibody Production Services Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, December 11, 2025 /⁨EINPresswire.com⁩/ -- The antibody production services …

Distribution channels: Business & Economy, Chemical Industry ...
Published on December 11, 2025 - 10:30 GMT

The Antimicrobial Resistance (AMR) Genotyping Panels Market is projected to reach a value of $2.46 Billion by 2029

The Business Research Company’s Antimicrobial Resistance (AMR) Genotyping Panels Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, December 11, 2025 /⁨EINPresswire.com⁩/ -- The …

Distribution channels: Business & Economy, Chemical Industry ...
Published on December 11, 2025 - 10:30 GMT

The Artificial Intelligence (AI) in Regulatory Affairs Market is Expected to Expand at a 22.8% CAGR Until 2029

The Business Research Company’s Artificial Intelligence (AI) in Regulatory Affairs Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, December 11, 2025 /⁨EINPresswire.com⁩/ -- The use of …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on December 11, 2025 - 10:30 GMT

Man-Portable Anti-Armor Weapons Market In 2029

The Business Research Company’s Man-Portable Anti-Armor Weapons Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, December 11, 2025 /⁨EINPresswire.com⁩/ -- Man-Portable Anti-Armor …

Distribution channels: Business & Economy, Emergency Services ...
Published on December 11, 2025 - 10:30 GMT

Bevacizumab Biosimilars Market Drivers 2025-2029: Regional Outlook and Sizing Analysis

The Business Research Company's Bevacizumab Biosimilars Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, December 11, 2025 /⁨EINPresswire.com⁩/ -- "Bevacizumab …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on December 11, 2025 - 10:30 GMT

IVF Services Market In 2029

The Business Research Company’s IVF Services Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, December 11, 2025 /⁨EINPresswire.com⁩/ -- IVF Services Market to Surpass $34 billion in …

Distribution channels: Business & Economy, Chemical Industry ...
Published on December 11, 2025 - 10:30 GMT

Antibody Validation Market Analysis, Growth Prospects, Market Share, Competitive Landscape, and Forecast to 2029

The Business Research Company’s Antibody Validation Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, December 11, 2025 /⁨EINPresswire.com⁩/ -- The antibody validation market is rapidly …

Distribution channels: Business & Economy, Chemical Industry ...
Published on December 11, 2025 - 10:30 GMT

Biosurfactants Market Competition Analysis 2025: How Players Are Shaping Growth

The Business Research Company’s Biosurfactants Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, December 11, 2025 /⁨EINPresswire.com⁩/ -- The Biosurfactants market is dominated by a …

Distribution channels: Business & Economy, Chemical Industry ...
Published on December 11, 2025 - 10:30 GMT

Analysis Report on Market Size, Share, and Trends of the Antimicrobial Regenerative Wound Matrix by Product

The Business Research Company’s Antimicrobial Regenerative Wound Matrix Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, December 11, 2025 /⁨EINPresswire.com⁩/ -- The antimicrobial …

Distribution channels: Business & Economy, Chemical Industry ...
Published on December 11, 2025 - 10:15 GMT

Medical Foods For Inborn Errors Of Metabolism Market In 2029

The Business Research Company's Medical Foods For Inborn Errors Of Metabolism Market In 2029 LONDON, GREATER LONDON, UNITED KINGDOM, December 11, 2025 /⁨EINPresswire.com⁩/ -- "Medical Foods For Inborn Errors Of Metabolism Market to …

Distribution channels: Business & Economy, Food & Beverage Industry ...
Published on December 11, 2025 - 10:00 GMT

IMLCC Approves Formation Of New Subsidiary – Offering Technology & Support Services To Medical Professional Compacts

An Extension Of IMLCC's Commitment To State-Based Licensure & Regulation - And It Could Improve Access To Care For Patients Across the US LITTLETON, CO, UNITED STATES, December 11, 2025 /⁨EINPresswire.com⁩/ -- The Interstate Medical …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on December 11, 2025 - 09:42 GMT

Precision Measurement Technologies Announces Strategic Partnership with Posifa Technologies

Precision Measurement Technologies Named Lead Technical Center and Distribution Partner for Posifa Technologies’ MEMS Sensor Solutions CLEARWATER, FL, UNITED STATES, December 11, 2025 /⁨EINPresswire.com⁩/ -- Precision Measurement Technologies (PMT …

Distribution channels: Aviation & Aerospace Industry, Electronics Industry ...
Published on December 11, 2025 - 09:36 GMT

CBM 2026 Launches Year-Long Business Framework to Help Chiropractors Build Profitable, Balanced Practices

IRVINE, CA, UNITED STATES, December 11, 2025 /⁨EINPresswire.com⁩/ -- As the chiropractic industry faces rising competition, increasing patient expectations, and greater operational complexity, Alpha Omega Consulting announces the upcoming launch of …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on December 11, 2025 - 09:30 GMT

Brain Tumor Drugs Market - Opportunities, Share, Growth and Competitive Analysis and Forecast 2029

The Business Research Company's Brain Tumor Drugs Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, December 11, 2025 /⁨EINPresswire.com⁩/ -- "What Is The Forecast For …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on December 11, 2025 - 09:20 GMT

Shockwave Therapy Expands Chiropractic Care by Accelerating Relief for Multiple Conditions

IRVINE, CA, UNITED STATES, December 11, 2025 /⁨EINPresswire.com⁩/ -- Chiropractic care continues to evolve as clinics adopt advanced therapies that help patients recover faster and perform better. Among these innovations, Shockwave Therapy is …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on December 11, 2025 - 09:15 GMT

Cell Therapy Market Size Worth $28.67 Billion by 2029 - Exclusive Report by The Business Research Company

The Business Research Company’s Cell Therapy Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, December 11, 2025 /⁨EINPresswire.com⁩/ -- How Much Is The Cell Therapy Market Worth …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on December 11, 2025 - 09:15 GMT

Over The Counter (OTC) Drugs Market Competition Analysis 2025: How Players Are Shaping Growth

The Business Research Company’s Over The Counter (OTC) Drugs Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, December 11, 2025 /⁨EINPresswire.com⁩/ -- The Over The Counter (OTC …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...